---
title: "Integrated multiomic MEGASCOREs improve prediction of MI, AF, HF, and CV death"
id: "medrxiv-21-integrated-multiomic-scores-for-cardiovascular-disease-prediction-across"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-21-integrated-multiomic-scores-for-cardiovascular-disease-prediction-across"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.23.26366372v1?rss=1"
published_at: "2026-10-28T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Integrated multiomic MEGASCOREs improve prediction of MI, AF, HF, and CV death
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-21-integrated-multiomic-scores-for-cardiovascular-disease-prediction-across
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.23.26366372v1?rss=1)
- **Published At:** 2026-10-28T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators derived disease-specific **proteomic** scores from 999 plasma proteins measured in 50,673 UK Biobank participants and then validated those protein-based signatures in an external cohort. - The study team combined validated proteomic scores with 2,279 **polygenic** scores and 479 DNA methylation scores to construct four integrated multiomic scores (MEGASCOREs) for myocardial infarction (MI), atrial fibrillation (AF), heart failure (HF), and cardiovascular mortality. - External validation occurred in 9,358 participants from the PURE study; two additional cohorts were used for pooled analyses and ancestry-specific evaluation, but the source did not list their names in the abstract. - In pooled analyses, each 1-SD increase in the corresponding **MEGASCORE** associated with increased hazard ratios: MI (HR 2.13), AF (HR 1.94), HF (HR 3.33), and cardiovascular mortality (HR 3.28), with 95% CIs reported in the abstract. - MEGASCOREs improved discrimination relative to clinical models; the largest gains were for HF and cardiovascular mortality. MEGASCORE-CV-Death achieved AUC 0.83 versus 0.78 for SCORE2 (both with 95% CIs reported). - The MEGASCORE-CV-Death discrimination exceeded SCORE2 across all four ancestry groups and showed better calibration in non-European groups, per the authors' pooled analyses. - The multiomic scores remained associated with cardiovascular outcomes in participants without conventional cardiovascular risk factors, indicating potential utility beyond standard clinical predictors. - The article is a preprint and has not been peer reviewed. The abstract did not report full details on cohort identities for the two additional validation cohorts, assay platforms, model construction parameters, nor prospective clinical-implementation data.
## Clinical Analysis & Structured Key Points
Integrated multiomic scores for cardiovascular disease prediction across multiancestral populations | medRxiv Skip to main content Integrated multiomic scores for cardiovascular disease prediction across multiancestral populations View ORCID Profile Pascal B Meyre , View ORCID Profile Michael Chong , View ORCID Profile Marie Pigeyre , Shihong Mao , View ORCID Profile Michael Kamal , View ORCID Profile Shrikant I Bangdiwala , Roya Kelishadi , View ORCID Profile Annika Rosengren , View ORCID Profile Fernando Lanas , Afzalhussein Yusufali , Rita Yusuf , Jephat Chifamba , View ORCID Profile Patricio Lopez-Jaramillo , Marc Evans M Abat , Alvaro Avezum Junior , Karen Yeates , María Luz Díaz , Hassan Mir , View ORCID Profile Bernard D Keavney , View ORCID Profile Sonia S. Anand , Koon Teo , View ORCID Profile Sumathy Rangarajan , Philip Joseph , View ORCID Profile Hertzel C. Gerstein , Salim Yusuf , View ORCID Profile Guillaume Paré doi: https://doi.org/10.64898/2026.10.23.26366372 Pascal B Meyre 1 Cardiology Department, University Hospital Basel; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Pascal B Meyre For correspondence: pascal.meyre{at}usb.ch Michael Chong 2 McMaster University / Population Health Research Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Michael Chong Marie Pigeyre 3 Population Health Research Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Marie Pigeyre Shihong Mao 3 Population Health Research Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Michael Kamal 4 McMaster University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Michael Kamal Shrikant I Bangdiwala 5 McMaster University Department of Health Research Methods Evidence and Impact; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Shrikant I Bangdiwala Roya Kelishadi 6 Isfahan University of Medical Sciences; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Annika Rosengren 7 Medicine, Gothenburg University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Annika Rosengren Fernando Lanas 8 Universidad de la Frontera Facultad de Medicina; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Fernando Lanas Afzalhussein Yusufali 9 Tamami Foundation; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Rita Yusuf 10 Independent University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jephat Chifamba 11 University of Zimbabwe; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Patricio Lopez-Jaramillo 12 Universidad de Santander; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Patricio Lopez-Jaramillo Marc Evans M Abat 13 Philippine General Hospital Taft Avenue; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Alvaro Avezum Junior 14 Â Hospital AlemÃo Oswaldo Cruz; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Karen Yeates 15 Queens University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site María Luz Díaz 16 Estudios Clínicos Latino América (ECLA); Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hassan Mir 17 University of Ottawa Heart Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Bernard D Keavney 18 The University of Manchester; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Bernard D Keavney Sonia S. Anand 4 McMaster University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Sonia S. Anand Koon Teo 4 McMaster University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sumathy Rangarajan 19 Population Health Research Institute, McMaster University Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Sumathy Rangarajan Philip Joseph 3 Population Health Research Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hertzel C. Gerstein 4 McMaster University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Hertzel C. Gerstein Salim Yusuf 3 Population Health Research Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Guillaume Paré 3 Population Health Research Institute; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Guillaume Paré Abstract Info/History Metrics Data/Code Preview PDF Abstract Background: Genomic, epigenomic, and proteomic data capture complementary aspects of cardiovascular disease biology, but the value of integrating these data for predicting multiple cardiovascular disease outcomes across ancestry groups remains uncertain. Methods: We derived disease-specific proteomic scores using 999 plasma proteins in 50,673 UK Biobank participants and validated them in 9,358 participants from the Prospective Urban and Rural Epidemiological (PURE) study. In PURE, we integrated these proteomic scores with 2,279 polygenic scores and 479 DNA methylation scores to develop 4 multiomic scores (MEGASCOREs) for myocardial infarction (MI), atrial fibrillation (AF), heart failure (HF), and cardiovascular mortality. Associations with incident cardiovascular disease, discrimination, calibration, and performance across ancestry groups were evaluated in PURE and 2 additional cohorts. Results: In pooled analyses, each standard deviation increase in the corresponding MEGASCORE was associated with MI (hazard ratio [HR], 2.13; 95% CI, 1.86-2.43), AF (HR, 1.94; 95% CI, 1.68-2.24), HF (HR, 3.33; 95% CI, 2.75-4.05), and cardiovascular mortality (HR, 3.28; 95% CI, 2.33-4.61). MEGASCOREs improved discrimination compared with clinical models, with strongest improvements for HF and cardiovascular mortality. MEGASCORE-CV-Death had a higher area under the receiver operating characteristic curve (AUC) than SCORE2 for cardiovascular mortality (0.83 [95% CI, 0.82-0.85] vs. 0.78 [95% CI, 0.77-0.80]). Its discrimination was also higher than that of SCORE2 across all 4 ancestry groups, with better calibration across non-European ancestry groups. MEGASCOREs remained associated with cardiovascular outcomes among participants without conventional cardiovascular risk factors. Conclusions: Integrated multiomic MEGASCOREs were associated with multiple cardiovascular outcomes and provided prognostic information beyond conventional clinical variables in PURE. Competing Interest Statement P.B.M. is supported by a postdoctoral research fellowship from the Swiss National Science Foundation, outside the submitted work. M.C. is supported by a Canadian Institute of Health Research doctoral award and has received consulting fees from Bayer. M.P. was supported by the E.J. Moran Campbell Internal Career Research Award from McMaster University and the Early Career Research Award from Hamilton Health Sciences (HHS). H.G. holds the McMaster-Sanofi Population Health Institute Chair in Diabetes Research and Care. He reports research grants from Eli Lilly, Novo Nordisk, and Hanmi; continuing education grants from Eli Lilly, Abbott, Sanofi, Novo Nordisk, and Boehringer Ingelheim; honoraria for speaking from AstraZeneca, Eli Lilly, Novo Nordisk, Zuellig, Sanofi, Carbon Brand, and Jiangsu Hanson; consulting fees from Abbott, Bayer, Eli Lilly, Novo Nordisk, Pfizer, Sanofi, and Hanmi; and holds a patent for the use of GDF15 as a biomarker for metformin intake. S.Y. is supported by the Heart and Stroke Foundation/Marion W Burke Chair in Cardiovascular Disease. G.P. is supported by the CISCO Professorship in Integrated Health Systems. The remaining authors have no competing interests. Clinical Trial NCT03225586 NCT03078166 NCT00069784 Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: All participants provided informed consent. UKB received ethical approval from the National Health Service (NHS) North West Centre for Research Ethics Committee (reference 11/NW/0382). Data were accessed under UKB application number 15255. PURE, G-CHF and ORIGIN were approved by the local ethics committees, and all participants provided written informed consent. Ethics Committee/Institutional Review Board were Hamilton Integrated Research Ethics Board (HiREB), Panel B, Hamilton, Ontario, Canada. Ethics decision: Ethical approval was granted. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability UK Biobank data are available upon request to qualified researchers through a standard protocol (https://www.ukbiobank.ac.uk/register-apply). Individual-level data from PURE, G-CHF or ORIGIN are not available to the public because participants did not consent to the sharing of their personal data outside the investigative team. Formal proposals for collaboration with other groups with similar data for pooled analyses will be considered. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted October 28, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Integrated multiomic scores for cardiovascular disease prediction across multiancestral populations Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Integrated multiomic scores for cardiovascular disease prediction across multiancestral populations Pascal B Meyre , Michael Chong , Marie Pigeyre , Shihong Mao , Michael Kamal , Shrikant I Bangdiwala , Roya Kelishadi , Annika Rosengren , Fernando Lanas , Afzalhussein Yusufali , Rita Yusuf , Jephat Chifamba , Patricio Lopez-Jaramillo , Marc Evans M Abat , Alvaro Avezum Junior , Karen Yeates , María Luz Díaz , Hassan Mir , Bernard D Keavney , Sonia S. Anand , Koon Teo , Sumathy Rangarajan , Philip Joseph , Hertzel C. Gerstein , Salim Yusuf , Guillaume Paré medRxiv 2026.10.23.26366372; doi: https://doi.org/10.64898/2026.10.23.26366372 Share This Article: Copy Citation Tools Integrated multiomic scores for cardiovascular disease prediction across multiancestral populations Pascal B Meyre , Michael Chong , Marie Pigeyre , Shihong Mao , Michael Kamal , Shrikant I Bangdiwala , Roya Kelishadi , Annika Rosengren , Fernando Lanas , Afzalhussein Yusufali , Rita Yusuf , Jephat Chifamba , Patricio Lopez-Jaramillo , Marc Evans M Abat , Alvaro Avezum Junior , Karen Yeates , María Luz Díaz , Hassan Mir , Bernard D Keavney , Sonia S. Anand , Koon Teo , Sumathy Rangarajan , Philip Joseph , Hertzel C. Gerstein , Salim Yusuf , Guillaume Paré medRxiv 2026.10.23.26366372; doi: https://doi.org/10.64898/2026.10.23.26366372 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (637) Allergy and Immunology (914) Anesthesia (348) Cardiovascular Medicine (4957) Dentistry and Oral Medicine (492) Dermatology (425) Emergency Medicine (674) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1678) Epidemiology (16182) Forensic Medicine (36) Gastroenterology (1236) Genetic and Genomic Medicine (7232) Geriatric Medicine (749) Health Economics (1092) Health Informatics (5241) Health Policy (1459) Health Systems and Quality Improvement (1818) Hematology (598) HIV/AIDS (1373) Infectious Diseases (except HIV/AIDS) (16447) Intensive Care and Critical Care Medicine (1196) Medical Education (692) Medical Ethics (156) Nephrology (742) Neurology (7531) Nursing (376) Nutrition (1117) Obstetrics and Gynecology (1290) Occupational and Environmental Health (1035) Oncology (3720) Ophthalmology (1082) Orthopedics (403) Otolaryngology (463) Pain Medicine (498) Palliative Medicine (143) Pathology (719) Pediatrics (1849) Pharmacology and Therapeutics (749) Primary Care Research (781) Psychiatry and Clinical Psychology (6081) Public and Global Health (9940) Radiology and Imaging (2506) Rehabilitation Medicine and Physical Therapy (1501) Respiratory Medicine (1263) Rheumatology (657) Sexual and Reproductive Health (796) Sports Medicine (595) Surgery (799) Toxicology (109) Transplantation (317) Urology (304)
## Related Clinical Research

- [GLP-1 drugs tied to lower diabetes progression and cardiovascular events than metformin](https://medichelpline.com/clinical-feed/aha-news-4-glp-1-meds-linked-to-lower-diabetes-heart-risks-than-standard-diabetes.md)
- [Comparing BMI, Waist Circumference, and BRI for Predicting ASCVD, AF, and Mortality in 1.2M Koreans](https://medichelpline.com/clinical-feed/plos-one-14-prognostic-associations-of-anthropometric-indices-with-major-health-outcomes-a.md)
- [Impact of Nighttime Light Exposure on Heart Health and Disease Risk](https://medichelpline.com/clinical-feed/medical-news-today-0-nighttime-light-exposure-may-alter-the-heart-and-increase-disease-risk.md)
- [Cardiometabolic pathways mediating the effect of educational attainment on cardiovascular disease:](https://medichelpline.com/clinical-feed/medrxiv-13-cardiometabolic-pathways-linking-genetically-proxied-educational-attainment-to.md)
- [Holiday surge in heart attack deaths: data, risks and practical precautions](https://medichelpline.com/clinical-feed/aha-news-0-heart-attack-deaths-peak-during-the-holiday-season.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.